Sialorrhea in children with cerebral palsy: updates on intervention possibilities
DOI:
https://doi.org/10.11606/issn.2317-0190.v32i3a240762Keywords:
Cerebral Palsy, Sialorrhea, Neurology, Therapeutics, ChildAbstract
Sialorrhea is a frequent comorbidity in children with cerebral palsy, with significant negative impact on personal, social, and educational domains, as well as on the quality of life of patients and their families. Objective: The aim of this clinical update was to review the literature and describe recent advances in the treatment of sialorrhea in children with cerebral palsy, highlighting available interventions and their effectiveness in clinical practice. Results: Evidence shows that management options include speech therapy, pharmacological treatments, application of botulinum toxin, behavioral strategies, and, in refractory cases, surgical procedures. Conclusion: Individualized and progressive management, preferably guided by a multidisciplinary team, is essential to reduce complications and optimize outcomes. However, there is still no consensus on the most effective approach, and gaps remain in the literature, particularly regarding long-term efficacy and comparative studies.
Downloads
References
Russo EF, Calabrò RS, Sale P, Vergura F, De Cola MC, Militi A, et al. Can muscle vibration be the future in the treatment of cerebral palsy-related drooling? A feasibility study. Int J Med Sci. 2019;16(11):1447-1452. Doi: https://doi.org/10.7150/ijms.34850
Gandhi K, Strychowsky JE, Chen BA. Pediatric sialorrhea (drooling). CMAJ. 2024;196(18):E624. Doi: https://doi.org/10.1503/cmaj.231550
Corso BL, Silveira VC, Binha AM, Chamlitian TR. Abordagem terapêutica na sialorréia em paralisia cerebral: revisão sistemática. Med Reabil. 2011;30(1):9-13
Reid SM, Johnson HM, Reddihough DS. The Drooling Impact Scale: a measure of the impact of drooling in children with developmental disabilities. Dev Med Child Neurol. 2010;52(2):e23-8. Doi: https://doi.org/10.1111/j.1469-8749.2009.03519.x
Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia. 1988;3(2):73-8. Doi: https://doi.org/10.1007/BF02412423
Cavalcanti NS, Sekine L, Manica D, Farenzena M, Saleh Neto CS, Marostica PJC, et al. Translation and validation of the drooling impact scale questionnaire into Brazilian Portuguese. Braz J Otorhinolaryngol. 2022;88(5):657-662. Doi: https://doi.org/10.1016/j.bjorl.2020.09.003
Sforza E, Onesimo R, Leoni C, Giorgio V, Proli F, Notaro F, et al. Drooling outcome measures in paediatric disability: a systematic review. Eur J Pediatr. 2022;181(7):2575-2592. Doi: https://doi.org/10.1007/s00431-022-04460-5
Hung SA, Liao CL, Lin WP, Hsu JC, Guo YH, Lin YC. Botulinum Toxin Injections for treatment of drooling in children with cerebral palsy: a systematic review and meta-analysis. Children (Basel). 2021;8(12):1089. Doi: https://doi.org/10.3390/children8121089
Speyer R, Cordier R, Kim JH, Cocks N, Michou E, Wilkes-Gillan S. Prevalence of drooling, swallowing, and feeding problems in cerebral palsy across the lifespan: a systematic review and meta-analyses. Dev Med Child Neurol. 2019;61(11):1249-1258. Doi: https://doi.org/10.1111/dmcn.14316
Dias BLS, Fernandes AR, Maia HS Filho. Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy. Arq Neuropsiquiatr. 2017;75(5):282-287. Doi: https://doi.org/10.1590/0004-282X20170033
Marquez-Vazquez JF, Arellano-Saldaña ME, Rojas-Martinez KN, Carrillo-Mora P. Comparative Efficacy of Botulinum Toxin in Salivary Glands vs. Oromotor therapy in the management of sialorrhea in cerebral palsy impact on sleep quality. Front Rehabil Sci. 2022;3:875235. Doi: https://doi.org/10.3389/fresc.2022.875235
McInerney MS, Reddihough DS, Carding PN, Swanton R, Walton CM, Imms C. Behavioural interventions to treat drooling in children with neurodisability: a systematic review. Dev Med Child Neurol. 2019;61(1):39-48. Doi: https://doi.org/10.1111/dmcn.14048
Mikami DLY, Furia CLB, Welker AF. Addition of Kinesio Taping of the orbicularis oris muscles to speech therapy rapidly improves drooling in children with neurological disorders. Dev Neurorehabil. 2019;22(1):13-18. Doi: https://doi.org/10.1080/17518423.2017.1368729
Pervez R, Naz S, Babur N, Mumtaz N. Effects of kinesio taping compared with manipulation therapy on drooling and speech intelligibility in children with oral dysphagia: a pilot study. Altern Ther Health Med. 2022;28(3):48-51.
Petkus KD, Noritz G, Glader L. Examining the role of sublingual atropine for the treatment of sialorrhea in patients with neurodevelopmental disabilities: a retrospective review. J Clin Med. 2023;12(16):5238. Doi: https://doi.org/10.3390/jcm12165238
Cunningham N. Pharmacological management of hypersalivation in children and adults. Norwich: NHS Norfolk & Waveney Medicines Optimisation Team; 2024.
Lima CR, Martins CL, Afonso E. Escopolamina Transdérmica no tratamento da sialorreia em patologia neurológica: revisão da literatura. SPMFR. 2023;35(1):20-8. Doi: https://doi.org/10.25759/spmfr.448
Delsing CPA, Adriaansens C, van Hulst K, Erasmus CE, van den Hoogen FJA. Long-term effects of submandibular gland excision on drooling in children with neurodevelopmental disorders: A cross-sectional study. Int J Pediatr Otorhinolaryngol. 2023;164:111377. Doi: https://doi.org/10.1016/j.ijporl.2022.111377
Gutierrez GM, Siqueira VL, Loyola-Rodriguez JP, Diniz MB, Guaré RO, Ferreira AC, et al. Effects of treatments for drooling on caries risk in children and adolescents with cerebral palsy. Med Oral Patol Oral Cir Bucal. 2019;24(2):204-210. Doi: https://doi.org/10.4317/medoral.22729
Riva A, Amadori E, Vari MS, Spalice A, Belcastro V, Viri M, et al. Impact and management of drooling in children with neurological disorders: an Italian Delphi consensus. Ital J Pediatr. 2022;48(1):118. Doi: https://doi.org/10.1186/s13052-022-01312-8
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Acta Fisiátrica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
O conteúdo do periódico está licenciado sob uma Licença Creative Commons BY-NC-SA. Esta licença permite que outros remixem, adaptem e criem a partir do seu trabalho para fins não comerciais, desde que atribuam ao autor o devido crédito e que licenciem as novas criações sob termos idênticos.
